Free Trial

Titan Pharmaceuticals (TTNP) Insider Trading & Ownership

Titan Pharmaceuticals logo
$4.20 -0.20 (-4.55%)
As of 03:28 PM Eastern

Titan Pharmaceuticals (NASDAQ:TTNP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.72%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$934.16K
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$4.17M
Get TTNP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Titan Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TTNP Insider Buying and Selling by Quarter

Titan Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2023David E. LazarCEOSell169,445$24.60$4,168,347.00  
1/24/2023David E LazarCEOBuy1,875$19.40$36,375.00  
7/6/2022David E LazarMajor ShareholderBuy58,298$15.40$897,789.20  
(Data available from 1/1/2013 forward)

TTNP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Titan Pharmaceuticals includes David E Lazar. Learn more on insiders at TTNP.

0.72% of Titan Pharmaceuticals stock is owned by insiders. Learn more on TTNP's insider holdings.



This page (NASDAQ:TTNP) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners